BioCatalyst

CRIS — CURIS INC catalysts

1 verified catalyst event(s) for CURIS INC (ticker CRIS). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-08-01 — CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in R · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08 (month)
in 1mo
ESTIMATED
 READOUT
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-
Phase 1/2 · Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy
 CRIS CURIS INC Emavusertib, Ibrutinib ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.